Prostate cancer treatment is trending toward risk-specific therapies

After decades of overtreatment for low-risk prostate cancer and inadequate management of its more aggressive forms, patients are now more likely to receive medical care matched to level of risk, according to a study published in JAMA.

Oncology Nurse Advisor